Special Warning : אזהרת שימוש

4.4   Special warnings and precautions for use
High volume infusion must be used under specific monitoring in patients with mild to moderate cardiac or pulmonary failure (for more severe conditions: see section 4.3).
Solutions containing sodium chloride should be administered with caution to patients with: − mild to moderate cardiac insufficiency, peripheral or pulmonary oedema or extracellular hyperhydration (for more severe conditions: see section 4.3).
− hypernatraemia, hyperchloraemia, hypertonic dehydration, hypertension, impaired renal function, present or imminent eclampsia, aldosteronism or other conditions or treatments with medicines (e.g. corticoids/steroids) associated with sodium retention (see also section 4.5).
Solutions containing potassium salts should be administered with caution to patients with cardiac disease or conditions predisposing to hyperkalaemia such as renal or adrenocortical insufficiency, acute dehydration or extensive tissue destruction as occurs with severe burns.
Because of the presence of calcium:
− Care should be taken to prevent extravasation during intravenous infusion − The solution should be given cautiously to patients with impaired renal function or diseases associated with elevated vitamin D concentrations such as sarcoidosis.
− In case of concomitant blood transfusion, the solution for infusion must not be administered via the same infusion set.
Solutions containing metabolisable anions should be administered cautiously to patients with respiratory impairment.
Monitoring of serum electrolytes, fluid balance and blood pH is necessary.
During long-term parenteral treatment, an adequate nutritive supply must be given to the patient.
This medicinal product contains 145 mmol sodium per 1,000 mL. This must be taken into consideration by patients on a controlled (low-) sodium diet.



Effects on Driving

4.7   Effects on ability to drive and use machines
Sterofundin ISO has no influence on the ability to drive and use machines.